Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000553

Drug Information
NameAtorvastatin    
Synonymsatorvastatine; atorvastatinium; UNII-A0JWA85V8F; (3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid; (betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid; Atorvastatin [INN:BAN]; Faboxim; (R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid; Sotis; BIDD:GT0336; atorvastatina; DB01076; AC-15611; CHEBI:39548; (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid; Sortis; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaR,deltaR)-; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-; atorvastatin; Tozalip; Lowden; Torvacard; Xarator; Zurinel; 134523-00-5; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R-(R*,R*))-; Atorvastatin (INN); MolPort-000-883-773; Torvast; C33H35FN2O5; CHEMBL1487; CCRIS 7159; 7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID; Atorpic; AKOS000281127; AC1L1TZT; CI 981; NCGC00159458-02; AC1Q1OZQ; 134523-03-8; 5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R-(R*,R*))-; C06834; Sincol; Lipitor (TN); Xavator; Totalip; Atogal; HSDB 7039; atrovastin; Vastina; Lipotropic; Atorlip; nchembio.301-comp8; Cardyl; Xanator; Sortis (TN); D07474; Lipitor(TM); Lipovastatinklonal; CID60823; Liprimar; Tulip; LS-136975    
Trade NameLipitor    
CompanyPfizer Pharmaceuticals    
IndicationHypercholesterolemiaApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnticholesteremic Agents    
CAS NumberCAS 134523-00-5
FormularC33H35FN2O5    
PubChem Compound IDCID 60823.    
PubChem Substance IDSID 9052.    
ChEBI39548;    
SuperDrug ATC IDC10AA05;    
SuperDrug CAS ID134523005;    
Target3-hydroxy-3-methylglutaryl-coenzyme A reductaseInhibitor[2]
Ref 1New drugs in development for the treatment of endometriosis. Expert Opin Investig Drugs. 2008 Aug;17(8):1187-202. To Reference
Ref 2Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes. Biopharm Drug Dispos. 2000 Dec;21(9):353-64. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543